Nicola Ferri’s Post

📊 Does your clinical practice have a large post-operative patient population? You need to be able to calculate Wells' risk assessment for the potential presence of a pulmonary embolism. How to Set Up Wells Criteria for PE in Google Sheets. A step towards objective and evidence-based practice in MSK care. Here's a step-by-step guide to creating the Wells criteria calculator in Google Sheets: Open a new Google Sheet In cell A1, enter "Wells Criteria for PE" Create headers in row 2: A2: Criteria B2: Points C2: Patient Score Enter the criteria in column A, rows 3-9: • Clinical signs/symptoms of DVT • PE is #1 diagnosis or equally likely • Heart rate > 100 bpm • Immobilization ≥ 3 days or surgery in last 4 weeks • Previous DVT/PE • Hemoptysis • Malignancy Enter corresponding points in column B: 3, 3, 1.5, 1.5, 1.5, 1, 1 In column C, create dropdown menus for each criterion: • Select C3:C9 • Data > Data validation • Criteria: List of items • Enter: 0, 1 In cell C10, sum the patient scores: • Formula: =SUMPRODUCT(B3:B9, C3:C9) In cell A12, enter "Risk Category" In B12, use this formula to categorize risk: =IF(C10>4, "PE Likely", "PE Unlikely") Now you have a functional Wells criteria calculator! Share this with your healthcare colleagues to improve PE risk stratification. https://lnkd.in/gk-vM3Qd #MedicalTechnology #ClinicalDecisionSupport #PulmonaryEmbolism

The classification algorithms to support the management of the patient with femur fracture https://lnkd.in/ds_KfHY9 Effectiveness in health care is a specific characteristic of each intervention and outcome evaluated. Especially with regard to surgical interventions, organization, structure and processes play a key role in ...

What do rheumatologists really want to know from MSK ultrasound scans that impact patient management? What findings could help with earlier diagnosis, treatment options, or patient education? Join Dr Anita Lee for a webinar on 12 September to discover discover the answers and take the opportunity to quiz a rheumatologist on how MSK ultrasound is impacting rheumatology practice. 🔗Register at https://ow.ly/PPJ550SZ0lP #Rheumatology #ultrasound #MSK #webinar #ASUM #ultrasoundexcellence #CPD

👨⚕️"𝐄𝐱𝐩𝐞𝐫𝐭𝐬 𝐎𝐩𝐢𝐧𝐢𝐨𝐧 𝐍𝐞𝐞𝐝𝐞𝐝" 𝐌𝐨𝐫𝐩𝐡𝐢𝐧𝐞 𝐏𝐚𝐢𝐧𝐤𝐢𝐥𝐥𝐞𝐫 𝐨𝐫 𝐊𝐢𝐥𝐥𝐞𝐫?😮 🕯 Morphine relieves pain by raising the #pain threshold at the spinal cord level and by altering the brain's perception of pain. 🕯 𝑾𝒉𝒂𝒕 𝒔𝒑𝒂𝒓𝒌𝒆𝒅 𝒕𝒉𝒆 #𝒄𝒐𝒏𝒕𝒓𝒐𝒗𝒆𝒓𝒔𝒚 𝒐𝒇 𝒖𝒔𝒊𝒏𝒈 𝒎𝒐𝒓𝒑𝒉𝒊𝒏𝒆 𝒊𝒏 𝑨𝒄𝒖𝒕𝒆 𝑪𝒐𝒓𝒐𝒏𝒂𝒓𝒚 𝑺𝒚𝒏𝒅𝒓𝒐𝒎𝒆 (ACS)? 🔎 CRUSADE Trial (2005): 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐦𝐨𝐫𝐭𝐚𝐥𝐢𝐭𝐲 𝐢𝐧 𝐍𝐨𝐧-𝐒𝐓 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐄𝐥𝐞𝐯𝐚𝐭𝐢𝐨𝐧 𝐀𝐂𝐒  • Patients treated with morphine did not receive optimal #medical treatment • Morphine use may indicate a more critically ill patient • Analgesia removes signs of severe angina • Morphine is #associated with delayed activity of P2Y12 inhibitors 🕯 𝐒𝐡𝐨𝐮𝐥𝐝 𝐦𝐨𝐫𝐩𝐡𝐢𝐧𝐞 𝐛𝐞 𝐮𝐬𝐞𝐝 𝐢𝐧 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐰𝐢𝐭𝐡 𝐀𝐂𝐒 𝐭𝐨 𝐡𝐞𝐥𝐩 𝐫𝐞𝐥𝐢𝐞𝐯𝐞 𝐩𝐚𝐢𝐧? 🤔 🔍 IV morphine alone or in combination with IV NTG is associated with a higher #risk of mortality, recurrent MI, CHF, and cardiogenic #shock in patients presenting with NSTE-ACS. 🔍 Use of morphine in patients with STEMI and planned Percutaneous Coronary intervention that has received a ticagrelor loading dose is associated with less TIMI 3 flow, more frequent use of GP IIb/IIIa inhibitors, and more #bleeding . 🕯 𝐅𝐢𝐧𝐚𝐥 𝐑𝐞𝐜𝐨𝐦𝐦𝐞𝐧𝐝𝐚𝐭𝐢𝐨𝐧: • Evidence does NOT support the safe use of morphine for pain relief in ACS. • Morphine should NOT be recommended routinely for ACS, especially in patients receiving #clopidogrel or ticagrelor before PCI according to current evidence. • There is insufficient evidence to make a #recommendation for morphine use in ACS in patients receiving prasugrel. • Theoretically, morphine may be used safely in patients receiving cangrelor as it is IV and therefore avoids #drug interaction. However, more research must be #conducted to determine #safety. 👉 Comment section is open to you all for any #additions , #suggestions , and valuable #opinions .🤝 𝐑𝐞𝐟𝐞𝐫𝐞𝐧𝐜𝐞, 1️⃣ https://lnkd.in/dgxS65Ys 2️⃣ https://lnkd.in/d8RathSW #medicalwriting #healthwriting #healthcareexcellence #knowledgesharing #painmanagement

The cancellation of spinal cord simulators by the TGA raises significant concerns about patient safety and the importance of rigorous oversight in medical devices. This development highlights the need for ongoing innovation and stringent standards to ensure that patients receive the safest and most effective treatments available. #Healthcare #PatientSafety #MedicalDevices #Innovation

Patient BMI is crucial when selecting the most appropriate SCS therapy. Traditional SCS implants, with their larger size, may not suit all patients, especially those with a lower BMI. At Nalu, our innovative micro-IPG technology ensures patient comfort with a minimally invasive procedure and zero reports of pocket site pain in the clinical literature*. This makes Nalu’s implant ideal for low BMI patients concerned about body cosmesis. SCS Clinical Profile for the Low BMI Patient: · Thin or frail and concerned about comfort and body cosmesis. Nalu Medical is leading the market in neurostimulation education & advocacy among physicians and advanced practice providers alike. Learn about future educational opportunities and emerging PNS indications by joining the Nalu Academy: https://lnkd.in/eXac8YMi #NaluMed #SCS #NaluAcademy #Neuromodulation #Treatmorepatients *REFERENCES: Salmon, John, et al. "Treating Chronic, Intractable Pain with a Miniaturized Spinal Cord Stimulation System: 1-Year Outcomes from the AUS-nPower Study During the COVID-19 Pandemic." Journal of Pain Research (2024): 293-304. Desai, Mehul J., et al. "Results from a prospective, clinical study (US-nPower) evaluating a miniature spinal cord Stimulator for the management of chronic, intractable pain." Pain physician 26.7 (2023): 575.

Denial Tip # 3   We are still in the denial letter.   Let’s look at the denial.   What was denied?   You may see a code and description. Examples: ·       74177 – Computed tomography abdomen and pelvis; with contrast material ·       81479 - Unlisted molecular pathology procedure code   You may only see a description. Examples: ·       Inpatient Hospital Stay ·       Acitretin 25 mg capsule Could you ensure that the item listed on the denial letter is the one actually needed and that your provider requested? Patients: Your provider has already discussed a care plan with you, so you are comparing what you know to what is on the letter. Providers: A quick comparison of the denial letter and office file can be made for verification.   Sometimes, pre-authorizations are submitted with the wrong CPT codes. Sometimes, items are left off as the request is processed and passed through different departments.   Please note what is denied. Add it to your list! This information will be used for research purposes later.   Any identified discrepancies could be highly advantageous for you.     #healthinsurance #nursesonlinkedin #qualityreview #utilizationreview #utilizationmanagement #appeals #grievance #denialsmangement #patientadvocate #ACA #ERISA #priorauthorization #healthcarereimbursement

Just because you are not a 'healthcare practitioner' does not mean you don't have enough personal and-or research knowledge to write an article looking at ways lifestyle medical principles can augment the allopathic treatment plan your doctor has set out. If you have deep vein thrombosis and would like to have some add-ons to the standard pharmaceuticals and a check-list of activities that could make a huge difference to managing the DVT, here ya go: https://lnkd.in/ggbwPmXS (Run it past your health care professional, by all means!)

Ilant Health, a comprehensive obesity and cardiometabolic company, published an Obesity Exclusive Insights White Paper. The paper reviews obesity trends, medical impact and costs driven by obesity related conditions, obesity treatment options comprising behavioral therapy, pharmacotherapy and bariatric surgery, and strategies to drive maximum value from obesity treatments. https://lnkd.in/epXWWi24

I was privileged to present to an ecclectic mix of clinicians ranging from GPs, cardiologists, renal physicians, peripheral vascular surgeons, endocrinologists and others at day 1 of the Australian Atherosclerosis Society Masterclass in Melbourne yesterday. With extensive expertise and clinical experience in the room, it was great that we in principle agree that: (1) it is imperative that obesity management be incorporated as part of the Cardiometabolic model of care (2) treating to target/ guidelines has been shown to be an effective strategy in secondary prevention of CV events in those with concomitant T2Dm & CVD (3) consider obesity as a gateway disease: manage this and then you will see an improvement in their dysglycaemia, dyslipidemia,hypertension etc as well as improved QoL eg reduced arthralgia etc It’s about time we as HCPs stop working in silos, and instead collaborate across different the different disciplines to provide patients with holistic personalised care